DPDP 3.5.2: DPDP and Data Analytics – Healthcare Analytics

Harini is the CFO of a mid-sized private hospital group in Tamil Nadu. The group had invested significantly in a business intelligence platform, which pulled data from their hospital management system, OPD records, pharmacy transactions, and diagnostic reports. The platform generated dashboards that the management team used for operational decisions — bed utilisation, consumable planning, department profitability, and patient retention.

At the end of the financial year, the analytics vendor offered a value-added service: a patient re-engagement module that would use the same data to identify patients who had not returned for follow-up visits and send them targeted health alerts via SMS and email. The hospital management approved the feature.

What the hospital had not done was revisit the consent it had obtained from patients at registration. That consent — collected through a standard hospital intake form — covered the processing of personal data for the provision of medical care and for billing purposes. It did not cover the use of diagnostic and prescription data for automated marketing outreach.

The DPDP Act Position

This scenario involves a textbook purpose limitation failure — one that also carries significantly aggravated risk because the personal data in question is health data.

First — Processing beyond the specified purpose under Section 8(1). Section 8(1) of the DPDP Act makes the Data Fiduciary responsible for compliance with the Act in respect of processing carried out by it or by any Data Processor on its behalf. The analytics vendor, when it ran the re-engagement module, was a Data Processor acting on the hospital’s behalf. Consequently, the hospital bears liability for this processing. The specified purpose under which patient data was collected was medical care and billing. Re-engagement marketing is not a purpose covered by that consent — regardless of whether the hospital subjectively considered it beneficial to patients.

Second — Data Processor contract inadequacy under Section 8(2). Section 8(2) requires the Data Fiduciary to ensure that its Data Processor processes personal data only for the specified purpose under a valid contract. The analytics vendor’s contract, in this case, covered the provision of BI dashboards and reporting. The re-engagement module was a new capability added under an expanded commercial arrangement — but without a corresponding update to the Data Processor contract to reflect the new processing purpose, and without fresh consent from patients for that purpose.

Third — Retention and purpose drift under Rule 8. Rule 8 of the DPDP Rules, 2025 governs the time period for which personal data may be retained once its specified purpose is served. Health data collected for a specific episode of care — an OPD visit, a diagnostic test — remains subject to the purpose for which it was collected. Feeding that data into a marketing analytics module after the specified purpose has been served is a purpose drift violation, compounded by the retention obligation.

The IS Audit 3.0 Perspective

IS Audit 3.0 by ICAI identifies data privacy and confidentiality as the leading challenge for data analytics deployments, specifically calling out the risk of data being misused once it is accessible to an analytics platform. Hospital management systems are among the most data-rich environments in any organisation. However, that richness also makes them among the highest-risk environments for purpose drift — the gradual expansion of analytics use cases beyond the original data collection purpose.

Importantly, IS Audit 3.0 material by ICAI also flags the risk that insufficient evidence is retained on file about the procedures and inputs used in analytics processing. In the hospital’s case, there was no audit trail linking the re-engagement module’s data inputs to a consent record. Consequently, if the Data Protection Board of India ever investigated, the hospital would be unable to demonstrate that lawful basis existed for the marketing processing.

The Compliance Fix

Healthcare organisations — and any organisation running analytics on data collected for a primary service purpose — must:

→ Conduct a purpose mapping exercise before activating any new analytics module. Every new use case must be traced back to a consent record that explicitly covers it.

→ Review and update all Data Processor contracts each time the analytics vendor introduces a new processing module or capability. Section 8(2) compliance requires the contract to reflect the actual processing being performed.

→ Maintain consent records that are granular enough to support an audit trail. “Patient consented to data processing” is not sufficient. The consent record must specify what data was covered, for what purpose, and at what point in time.

→ Apply purpose limitation controls at the analytics platform level — configure data access so that each module can only access the data categories covered by the relevant consent record.

→ Obtain fresh, specific consent before using health data for any purpose beyond direct patient care and billing — including patient outreach, marketing, research, and quality benchmarking.

Harini’s hospital had good intentions. However, the DPDP Act governs outcomes, not intentions. Unlawful processing remains unlawful even when it is well-meaning.

The compliance deadline is 13 May 2027. Health data analytics is high-risk processing. Its governance must match that risk.


Disclaimer

The contents of this post are intended for general awareness and informational purposes only. They do not constitute legal opinion, professional advice, consultancy, statutory interpretation, or a recommendation to act in any particular manner.

The Digital Personal Data Protection Act, 2023, related rules, notifications, regulatory guidance and judicial interpretations may evolve from time to time. The applicability of the law may also vary depending on the facts, sector, nature of data processing, organisational role, contractual terms and compliance framework.

Readers should not rely solely on this post for making legal, business, HR, technology, data-processing or compliance decisions. Specific advice from a qualified legal, privacy, cybersecurity, governance or compliance professional should be obtained before acting on any matter discussed.

The author / publisher shall not be responsible for any loss, liability, claim, penalty or consequence arising from reliance on the contents of this post without independent professional advice.


Authors: This article has been co-authored by CA. Sunil Elayadath and CA. Karthik Narayanan S, Partners of Karthik & Sunil, together with Mr. Dhanesh P. K., Designated Partner, DSK Sustainability Tech.

DPDP 3.5.2: DPDP and Data Analytics – Healthcare Analytics

DPDP 3.4.1: DPDP and Internet of Things (IoT) – Case Study 1 –  When Every Device Becomes a Witness

INTRODUCTION

IoT and DPDP compliance represent one of the most underestimated challenges in India’s data protection landscape today.

Your fitness band knows your resting heart rate. Your smart meter knows when you wake up. Your office access badge knows exactly where you were at 9:14 am. Individually, each of these data points seems harmless. Together, however, they compose a surveillance portrait of extraordinary detail — one that its subject never agreed to provide and may not even know exists.

This is precisely the privacy risk that IS Audit 3.0 (ICAI Module 6, Section 6.5.6) identifies when it notes that IoT devices collect and aggregate fragments of data that, in combination, can reveal religion, health information, lifestyle choices, and other sensitive personal attributes — even when no single data point appears sensitive in isolation.

The Internet of Things is defined in IS Audit 3.0 (Module 6, Section 6.5.1) as a system of interrelated computing devices, mechanical and digital machines, objects, animals, or people that are provided with unique identifiers and the ability to transfer data over a network without requiring human-to-human or human-to-computer interaction. In simple terms, devices collect, send, and act on data — largely without human involvement at the point of collection.

That last phrase is the compliance problem. The DPDP Act, 2023 is built on the premise of informed, specific, and free consent. IoT is built on the premise of seamless, continuous, and frictionless data collection. These two architectures sit in fundamental tension — and that tension has a deadline: 13 May 2027.

Three Case Study bring this tension to life.


Case Study 1 — Rohini’s Wearable and the Insurance Company That Knew Too Much

The Scenario

Rohini is a 41-year-old schoolteacher in Pune. She purchased a health insurance policy from a mid-sized insurer. As part of a wellness incentive programme, the insurer offered her a discount in exchange for syncing her fitness wearable to their app. Rohini agreed, expecting only her step count to be shared.

Over eighteen months, the wearable transmitted her heart rate variability, sleep patterns, stress indicators, menstrual cycle data, and location history to the insurer’s cloud platform. The insurer’s algorithm then recalculated her risk profile — and at renewal, her premium increased substantially. No one told Rohini that these data points were being collected, how they were being used, or that they would influence her premium.

The DPDP Act Position

Rohini’s situation discloses at least three distinct violations.

First — Consent specificity failure under Section 6(1). The DPDP Act requires consent to be free, specific, informed, unconditional, and unambiguous. It must be limited to personal data that is necessary for the specified purpose. Rohini consented to sharing her step count for a wellness discount. She did not consent to the sharing of menstrual cycle data, stress indicators, or sleep patterns. Any processing beyond the specified purpose is unlawful.

Rule 3 of the DPDP Rules, 2025 reinforces this directly. A Data Fiduciary must give notice in clear and plain language, with an itemised description of personal data to be collected and a specific description of the purpose. A general reference to “health data” does not satisfy this standard. Each category of IoT data being collected must be identified separately in the consent notice.

Second — Purpose limitation failure under Section 8(1). The purpose for which Rohini’s data was processed — premium recalculation — was never disclosed as a specified purpose at the time of consent. Consequently, processing her data for that purpose is unlawful under the Act, regardless of what the policy fine print may say.

Third — Sensitive personal data processing without adequate basis. Menstrual cycle data and health metrics constitute personal health information. While the DPDP Act does not yet have a separate “sensitive personal data” category in the manner of some foreign frameworks, Section 8(5) requires the Data Fiduciary to implement reasonable security safeguards. Moreover, when data is used to make a decision that affects the Data Principal, Section 8(3) requires the Data Fiduciary to ensure completeness, accuracy, and consistency of that data. An algorithmic premium revision based on wearable data must meet this standard.

The IS Audit 3.0 Perspective

IS Audit 3.0 (Module 6, Section 6.5.6) specifically identifies privacy concerns in healthcare IoT as a primary risk, observing that devices in this domain collect at least one piece of personal information and that the aggregation of IoT data fragments can reveal health information that was never explicitly disclosed. This aggregation risk is precisely what happened to Rohini.

Furthermore, IS Audit 3.0 (Section 6.5.7) identifies governance of IoT data as requiring a clear reference architecture, defined governance processes, and lifecycle management of the data managed by the IoT solution — none of which the insurer had implemented.

The Compliance Fix

Insurers and any organisation using wearable or health IoT data must:

→ Issue a separate, itemised consent notice for each data category collected by the device — not a single bundled consent covering “health data.” → Clearly specify every downstream use — including risk assessment, pricing, and underwriting decisions — as a stated purpose at the time of initial consent. → Ensure that data collected via wearable integration is not used for purposes beyond what was disclosed, unless fresh consent is obtained for the new purpose. → Implement data minimisation controls at the IoT gateway level, so that only the specific data categories covered by consent are transmitted to the cloud platform.

Rohini’s insurer collected far more than it disclosed. The DPDP Act calls that a violation — not a feature.

Rohini’s insurer had a wellness programme. It did not have a consent programme. Under the DPDP Act, that distinction matters enormously. The compliance deadline is 13 May 2027.

Disclaimer

The contents of this post are intended for general awareness and informational purposes only. They do not constitute legal opinion, professional advice, consultancy, statutory interpretation, or a recommendation to act in any particular manner.

The Digital Personal Data Protection Act, 2023, related rules, notifications, regulatory guidance and judicial interpretations may evolve from time to time. The applicability of the law may also vary depending on the facts, sector, nature of data processing, organisational role, contractual terms and compliance framework.

Readers should not rely solely on this post for making legal, business, HR, technology, data-processing or compliance decisions. Specific advice from a qualified legal, privacy, cybersecurity, governance or compliance professional should be obtained before acting on any matter discussed.

The author / publisher shall not be responsible for any loss, liability, claim, penalty or consequence arising from reliance on the contents of this post without independent professional advice.


Authors:
This article has been co-authored by CA. Sunil Elayadath and CA. Karthik Narayanan S, Partners of Karthik & Sunil, together with Mr. Dhanesh P. K., Designated Partner, DSK Sustainability Tech.

DPDP 3.4.1: DPDP and Internet of Things (IoT) – Case Study 1 –  When Every Device Becomes a Witness

DPDP 3.3.2 : DPDP and Blockchain – Case Study 2 – Meera’s Story

She withdrew consent. The blockchain remembered anyway.

Meera consented to her medical data being stored on a hospital’s blockchain network. Three years later, she withdrew that consent and asked for her records to be removed.

The hospital recorded her withdrawal correctly. However, her personal data had already been distributed across six network nodes. Those nodes — each holding a copy — were not instructed to delete anything.

Under Section 6(4) of the DPDP Act, 2023, withdrawal of consent must be as easy as giving it. Under Section 8(1), the Data Fiduciary must cease all processing upon withdrawal. Under Section 8(2), every entity processing personal data on the Data Fiduciary’s behalf — effectively, every node — must operate under a written contract limiting processing to the specified purpose.

Meera’s hospital had a consent withdrawal mechanism. However, they had no node governance framework. That gap is the compliance failure.

IS Audit 3.0 Study material of  ICAI (Module 6) flags precisely this risk: not all data on a distributed ledger should be accessible to others, and interoperability between chains creates additional exposure that is often overlooked in deployment planning.

Three things organisations deploying blockchain for sensitive personal data must do:

→ Map every node as a potential Data Processor. Execute written contracts under Section 8(2) before deployment.
→ Design consent withdrawal to trigger cascading deletion or encryption-key revocation across all nodes simultaneously.
→ Never write raw personal data to the chain. Use pseudonymous identifiers on-chain, with personal data in a governed, erasable off-chain repository.

Meera’s hospital is rebuilding its architecture. Consequently, the cost is now far higher than it would have been at design stage.

The DPDP Act compliance deadline is 13 May 2027. Node governance is not optional.

Disclaimer

The contents of this post are intended for general awareness and informational purposes only. They do not constitute legal opinion, professional advice, consultancy, statutory interpretation, or a recommendation to act in any particular manner.

The Digital Personal Data Protection Act, 2023, related rules, notifications, regulatory guidance and judicial interpretations may evolve from time to time. The applicability of the law may also vary depending on the facts, sector, nature of data processing, organisational role, contractual terms and compliance framework.

Readers should not rely solely on this post for making legal, business, HR, technology, data-processing or compliance decisions. Specific advice from a qualified legal, privacy, cybersecurity, governance or compliance professional should be obtained before acting on any matter discussed.

The author / publisher shall not be responsible for any loss, liability, claim, penalty or consequence arising from reliance on the contents of this post without independent professional advice.


Authors:
This article has been co-authored by CA. Sunil Elayadath and CA. Karthik Narayanan S, Partners of Karthik & Sunil, together with Mr. Dhanesh P. K., Designated Partner, DSK Sustainability Tech.

DPDP 3.3.2 : DPDP and Blockchain – Case Study 2 – Meera’s Story